ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis (Q43647241)
Jump to navigation
Jump to search
scientific article published in June 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis |
scientific article published in June 2001 |
Statements
1 reference
ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis (English)
1 reference
Nakajima A
1 reference
Tauchi T
1 reference
Ohyashiki K
1 reference
1 June 2001
1 reference
Identifiers
1 reference